Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy

Hum Gene Ther. 2002 Aug 10;13(12):1505-14. doi: 10.1089/10430340260185139.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae* / immunology
  • Antibodies, Viral / blood*
  • Antibodies, Viral / genetics
  • Antibodies, Viral / immunology
  • Ascites / immunology*
  • Female
  • Genetic Therapy*
  • Genetic Vectors*
  • Humans
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / immunology*
  • Ovarian Neoplasms / therapy*

Substances

  • Antibodies, Viral